Search Results
Joint Bookrunner on Perspective Therapeutics Registered Direct Offering
Oppenheimer & Co. Inc. acted as Joint Bookrunner on Perspective Therapeutics’ $80MM Registered Direct Offering
Joint Bookrunner on Capricor Therapeutics' Public Offering of Common Stock
Oppenheimer &. Co. Inc. acted as Joint Bookrunner on Capricor Therapeutics’ $86.3MM Confidentially Marketed Public Offering of Common Stock
Joint Bookrunner on Protara Therapeutics' Confidentially Marketed Public Offering
Oppenheimer & Co. Inc. acted as Joint Bookrunner on Protara Therapeutics’ Confidentially Marketed Public Offering of Approximately $100M
Joint Bookrunner on ProQR Therapeutics N.V.'s Confidentially Marketed Public Offering
Oppenheimer & Co. Inc. acted as Joint Bookrunner on ProQR Therapeutics N.V.’s $69.8MM Confidentially Marketed Public Offering
Financial Advisor to American Travel Solutions, LLC
Oppenheimer & Co. Inc acted as Financial Advisor to American Travel Solutions, LLC on its Acquisition by TravelPerk, Inc.
Financial Advisor to AlTi Global, Inc. on its acquisition of East End Advisors, LLC
Oppenheimer & Co. Inc. acted as Financial Advisor to AlTi Global, Inc. on its acquisition of East End Advisors, LLC
Exclusive Financial Advisor to Merit Medical Systems, Inc. on its Asset Purchase of EndoGastric Solutions, Inc.
Oppenheimer & Co. Inc. acted as Exclusive Financial Advisor to Merit Medical Systems, Inc. on its $105 million asset purchase of EndoGastric Solutions, Inc.
Financial Adviser to Vandemoortele on its Acquisition of Dolciaria Acquaviva
Oppenheimer’s European Consumer Investment Banking Team is pleased to have acted as Financial Adviser to Vandemoortele on its acquisition of Dolciaria Acquaviva from Apheon and the Acquaviva Family
Exclusive Global Fundraising Adviser to CONSTELLATION Capital AG
Oppenheimer Europe Ltd. is pleased to have partnered and worked with CONSTELLATION CAPITAL AG as their exclusive global fundraising adviser on the fundraising of CONSTELLATION VI
Exclusive Financial Advisor to TRiCares SAS on its Investment from a Strategic Investor
Oppenheimer & Co. Inc. acted as Exclusive Financial Advisor to TRiCares SAS on its $50 million investment from a strategic investor